(Joshua Cohen/ Forbes) — While Novavax hasn’t yet sought approval by the Food and Drug Administration (FDA) for its more conventional Covid-19 vaccine, it has recently applied for licensing its vaccine in Australia, Canada, Indonesia, New Zealand, and the U.K. This hasn’t gained much traction in the U.S. media, which  …